GCC
NVO

Game Creek Capital’s Novo Nordisk NVO Stock Holding History

Game Creek Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,250
Closed -$1.29M – 104
2025
Q3 		$1.29M Buy
+23,250
New +$1.36M 0.45% 65
2018
Q1 		– Sell
-62,800
Closed -$1.69M – 185
2017
Q4 		$1.69M Buy
+62,800
New +$1.6M 0.47% 50

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Game Creek Capital's NVO Position: Q4 2025 in Review

Game Creek Capital sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 23,250 shares — an estimated $1.29M sold.

Game Creek Capital first reported a position in NVO in Q4 2017 and held it in 2 quarters. The position peaked at $1.69M in Q4 2017. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Game Creek Capital reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Game Creek Capital sold 23,250 Novo Nordisk shares in Q4 2025, an estimated $1.29M.
  • Game Creek Capital first reported a position in Novo Nordisk in Q4 2017 and held it in 2 quarters.
  • Game Creek Capital's Novo Nordisk position peaked at $1.69M in Q4 2017.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Game Creek Capital's 13F filing for Q4 2025, filed 17 Feb 2026.